Coverart for item
The Resource Immunotherapy of cancer, edited by Mary L. Disis

Immunotherapy of cancer, edited by Mary L. Disis

Label
Immunotherapy of cancer
Title
Immunotherapy of cancer
Statement of responsibility
edited by Mary L. Disis
Contributor
Subject
Language
eng
Cataloging source
DLC
Illustrations
illustrations
Index
index present
Literary form
non fiction
Nature of contents
bibliography
http://library.link/vocab/relatedWorkOrContributorName
Disis, Mary L
Series statement
Cancer drug discovery and development
http://library.link/vocab/subjectName
  • Cancer
  • Antineoplastic agents
  • Neoplasms
  • Antineoplastic Agents
  • Immunotherapy
  • Vaccines
Label
Immunotherapy of cancer, edited by Mary L. Disis
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Contents
  • Sebastian Kreiter
  • Ugur Sahin
  • p. 1
  • 1.
  • Discovery of target molecules for cancer immunotherapy by genetic and bioinformatic approaches/
  • Ozlem Tureci
  • Thorsten Klamp
  • Michael Koslowski
  • Thomas Flad
  • Ashley Knights
  • Robert Rees
  • Graham Pawelec
  • p. 21
  • 2.
  • Current strategies for the identification of immunogenic epitopes of tumor antigens/
  • Ludmila Muller
  • Stephanie McArdle
  • Evelyna Derhovanessian
  • 3.
  • Current and future role of natural-killer cells in cancer immunotherapy/
  • Lisa M. Harlan
  • Julie Y. Djeu
  • p. 45
  • 4.
  • role of immune monitoring in evaluating cancer immunotherapy/
  • Holden T. Maecker
  • p. 59
  • 5.
  • Statistical analysis of immune response assays in cancer immunotherapy trials/
  • Susan Groshen
  • p. 73
  • 6.
  • DNA vaccines for cancer immunotherapy/
  • Heesun Kwak
  • Howard L. Kaufman
  • p. 87
  • 7.
  • Dendritic cells/
  • Weiping Zou
  • Tyler J. Curiel
  • p. 115
  • 8.
  • Different approaches to dendritic cell-based cancer immunotherapy/
  • Noweeda Mirza
  • Dmitry Gabrilovich
  • p. 127
  • Asim Saha
  • Rakesh Shukla
  • Kenneth A. Foon
  • p. 139
  • 9.
  • Anti-idiotype antibody vaccines for the immunotherapy of cancer/
  • Malaya Bhattacharya-Chatterjee
  • Nitin Rohatgi
  • Sunil K. Chatterjee
  • 10.
  • Autologous tumor-derived heat shock protein vaccine as a new paradigm for individualized cancer therapeutics/
  • Jie Dai
  • Zihai Li
  • p. 151
  • Heinke Conrad
  • Dirk H. Busch
  • Christian Peschel
  • p. 167
  • 11.
  • Tumor-reactive t-cells for adoptive immunotherapy/
  • Helga Bernhard
  • Julia Neudorfer
  • Kerstin Gebhard
  • p. 181
  • 12.
  • T-cell adoptive immunotherapy of cancer : from translational models to clinical significance/
  • Peter A. Cohen
  • Mohamed Awad
  • Suyu Shu
  • 13.
  • Retroviral-mediated gene transfer for engineering tumor-reactive t-cells/
  • Jeffrey J. Roszkowski
  • Michael I. Nishimura
  • p. 213
  • 14.
  • Harnessing the potential of graft-vs-tumor/
  • Nancy H. Hardy
  • Michael R. Bishop
  • p. 235
  • 15.
  • Tumor-induced immune suppression and immune escape : mechanisms and impact on the outcome of immunotherapy of malignant disease/
  • Michael Campoli
  • Soldano Ferrone
  • p. 263
  • 16.
  • tumor microenvironment : regulation of antitumor immunity and implications for immunotherapy/
  • George Coukos
  • Jose-Ramon Conejo-Garcia
  • p. 285
  • 17.
  • Manipulation of lymphocyte homeostasis for enhancing antitumor immunity/
  • Eduardo Davila
  • Esteban Celis
  • p. 303
  • 18.
  • Fast-lane evolution in the tumor microenvironment/
  • Gabriella Marincola
  • Francesco M. Marincola
  • p. 317
  • p. 331
  • 19.
  • Manipulating immunological checkpoints to maximize antitumor immunity/
  • Leisha A. Emens
  • R. Todd Reilly
  • Elizabeth M. Jaffee
  • 20.
  • Interleukin-2 as cancer therapy/
  • Joseph I. Clark
  • Kim A. Margolin
  • p. 355
  • p. 365
  • 21.
  • Biological and clinical properties of the type 1 interferons/
  • Douglas W. Leaman
  • Shaun Rosebeck
  • Ernest C. Borden
  • 22.
  • Promising [gamma]-chain cytokines for cancer immunotherapy : interleukins-7, -15, and -21 as vaccine adjuvants, growth factors and immunorestoratives/
  • Terry J. Fry
  • Crystal L. Mackall
  • p. 397
  • 23.
  • therapeutic use of natural-killer cells in hematological malignancies/
  • Sherif S. Farag
  • Michael A. Caligiuri
  • p. 415
  • p. 433
  • 24.
  • Antibody therapy for solid tumors/
  • Cristina I. Truica
  • Dorinda Rouch
  • Carlos L. Arteaga
  • 25.
  • Antibody therapy for non-Hodgkin's lymphoma/
  • Stephen M. Ansell
  • Thomas E. Witzig
  • p. 445
  • David A. Mankoff
  • Keith L. Knutson
  • p. 457
  • 26.
  • Approaches to in vivo imaging of cancer immunotherapy/
  • George A. Vielhauer
  • Bond Almand
  • Mary L. Disis
  • 27.
  • Design issues for early-stage clinical trials for cancer vaccines/
  • Gina R. Petroni
  • p. 479
  • p. 487
  • 28.
  • Monoclonal antibody therapy of cancer/
  • Hossein Borghaei
  • Matthew K. Robinson
  • Louis M. Weiner
Control code
UCD-002495521
Dimensions
26 cm.
Extent
xii, 516 p.
Isbn
9781588295644
Isbn Type
(alk. paper)
Lccn
2005017065
Other physical details
ill.
Label
Immunotherapy of cancer, edited by Mary L. Disis
Publication
Bibliography note
Includes bibliographical references and index
Contents
  • Sebastian Kreiter
  • Ugur Sahin
  • p. 1
  • 1.
  • Discovery of target molecules for cancer immunotherapy by genetic and bioinformatic approaches/
  • Ozlem Tureci
  • Thorsten Klamp
  • Michael Koslowski
  • Thomas Flad
  • Ashley Knights
  • Robert Rees
  • Graham Pawelec
  • p. 21
  • 2.
  • Current strategies for the identification of immunogenic epitopes of tumor antigens/
  • Ludmila Muller
  • Stephanie McArdle
  • Evelyna Derhovanessian
  • 3.
  • Current and future role of natural-killer cells in cancer immunotherapy/
  • Lisa M. Harlan
  • Julie Y. Djeu
  • p. 45
  • 4.
  • role of immune monitoring in evaluating cancer immunotherapy/
  • Holden T. Maecker
  • p. 59
  • 5.
  • Statistical analysis of immune response assays in cancer immunotherapy trials/
  • Susan Groshen
  • p. 73
  • 6.
  • DNA vaccines for cancer immunotherapy/
  • Heesun Kwak
  • Howard L. Kaufman
  • p. 87
  • 7.
  • Dendritic cells/
  • Weiping Zou
  • Tyler J. Curiel
  • p. 115
  • 8.
  • Different approaches to dendritic cell-based cancer immunotherapy/
  • Noweeda Mirza
  • Dmitry Gabrilovich
  • p. 127
  • Asim Saha
  • Rakesh Shukla
  • Kenneth A. Foon
  • p. 139
  • 9.
  • Anti-idiotype antibody vaccines for the immunotherapy of cancer/
  • Malaya Bhattacharya-Chatterjee
  • Nitin Rohatgi
  • Sunil K. Chatterjee
  • 10.
  • Autologous tumor-derived heat shock protein vaccine as a new paradigm for individualized cancer therapeutics/
  • Jie Dai
  • Zihai Li
  • p. 151
  • Heinke Conrad
  • Dirk H. Busch
  • Christian Peschel
  • p. 167
  • 11.
  • Tumor-reactive t-cells for adoptive immunotherapy/
  • Helga Bernhard
  • Julia Neudorfer
  • Kerstin Gebhard
  • p. 181
  • 12.
  • T-cell adoptive immunotherapy of cancer : from translational models to clinical significance/
  • Peter A. Cohen
  • Mohamed Awad
  • Suyu Shu
  • 13.
  • Retroviral-mediated gene transfer for engineering tumor-reactive t-cells/
  • Jeffrey J. Roszkowski
  • Michael I. Nishimura
  • p. 213
  • 14.
  • Harnessing the potential of graft-vs-tumor/
  • Nancy H. Hardy
  • Michael R. Bishop
  • p. 235
  • 15.
  • Tumor-induced immune suppression and immune escape : mechanisms and impact on the outcome of immunotherapy of malignant disease/
  • Michael Campoli
  • Soldano Ferrone
  • p. 263
  • 16.
  • tumor microenvironment : regulation of antitumor immunity and implications for immunotherapy/
  • George Coukos
  • Jose-Ramon Conejo-Garcia
  • p. 285
  • 17.
  • Manipulation of lymphocyte homeostasis for enhancing antitumor immunity/
  • Eduardo Davila
  • Esteban Celis
  • p. 303
  • 18.
  • Fast-lane evolution in the tumor microenvironment/
  • Gabriella Marincola
  • Francesco M. Marincola
  • p. 317
  • p. 331
  • 19.
  • Manipulating immunological checkpoints to maximize antitumor immunity/
  • Leisha A. Emens
  • R. Todd Reilly
  • Elizabeth M. Jaffee
  • 20.
  • Interleukin-2 as cancer therapy/
  • Joseph I. Clark
  • Kim A. Margolin
  • p. 355
  • p. 365
  • 21.
  • Biological and clinical properties of the type 1 interferons/
  • Douglas W. Leaman
  • Shaun Rosebeck
  • Ernest C. Borden
  • 22.
  • Promising [gamma]-chain cytokines for cancer immunotherapy : interleukins-7, -15, and -21 as vaccine adjuvants, growth factors and immunorestoratives/
  • Terry J. Fry
  • Crystal L. Mackall
  • p. 397
  • 23.
  • therapeutic use of natural-killer cells in hematological malignancies/
  • Sherif S. Farag
  • Michael A. Caligiuri
  • p. 415
  • p. 433
  • 24.
  • Antibody therapy for solid tumors/
  • Cristina I. Truica
  • Dorinda Rouch
  • Carlos L. Arteaga
  • 25.
  • Antibody therapy for non-Hodgkin's lymphoma/
  • Stephen M. Ansell
  • Thomas E. Witzig
  • p. 445
  • David A. Mankoff
  • Keith L. Knutson
  • p. 457
  • 26.
  • Approaches to in vivo imaging of cancer immunotherapy/
  • George A. Vielhauer
  • Bond Almand
  • Mary L. Disis
  • 27.
  • Design issues for early-stage clinical trials for cancer vaccines/
  • Gina R. Petroni
  • p. 479
  • p. 487
  • 28.
  • Monoclonal antibody therapy of cancer/
  • Hossein Borghaei
  • Matthew K. Robinson
  • Louis M. Weiner
Control code
UCD-002495521
Dimensions
26 cm.
Extent
xii, 516 p.
Isbn
9781588295644
Isbn Type
(alk. paper)
Lccn
2005017065
Other physical details
ill.

Library Locations

    • Harold Cohen LibraryBorrow it
      Ashton Street, Liverpool, L69 3DA, GB
      53.418074 -2.967913
Processing Feedback ...